R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

TSS vaccine: a breakthrough and potential other applications

A recent Biomedical Research & Bio-Products AG phase 2 study showed that its TSST-1 vaccine is safe and effective against Staphylococcal-induced Toxic Shock Syndrome (

Sales & Marketing

Transforming healthcare: Nils Bottler and Paul Tunnah

This podcast was produced in partnership with Angelini Ventures and was originally published on Matthew Holt’s

R&D

Gender equity relies on health equity

Global health relies on women’s health.

R&D

Chronic kidney disease: Challenges and upcoming technologies

Highlighting the impact of kidney disease, and promoting awareness and research, is crucial.

Patients

Challenges and opportunities with plasma-derived therapies

This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.

R&D

Open science: disrupting scientific community collaboration

The quiet rise of collaboration among pharma companies has never been more important.